Dr. Reddy's Laboratories Ltd Q4FY21 consolidated PAT jumps QoQ to Rs. 553.5 crore

DR.REDDY'S LABORATORIES LTD. has reported financial results for the period ended March 31, 2021.

Financial Results (Q4 FY20-21) - QoQ Comparison

The company has reported total income of Rs.4850.8 crores during the period ended March 31, 2021 as compared to Rs.5012.4 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.557.3 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.27.9 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.33.51 for the period ended March 31, 2021 as compared to Rs.1.67 for the period ended December 31, 2020.

Financials	Q4 FY20-21	Q3 FY20-21	% Change
Total Income	₹ 4850.8 crs	₹ 5012.4 crs	-3.22%
Net Profit	₹ 557.3 crs	₹ 27.9 crs	1897.49%
EPS	₹ 33.51	₹ 1.67	1906.59%

Financial Results (Q4 FY20-21) - YoY Comparison

The company has reported total income of Rs.4850.8 crores during the period ended March 31, 2021 as compared to Rs.4522.5 crores during the period ended March 31, 2020.

The company has posted net profit / (loss) of Rs.557.3 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.781.1 crores for the period ended March 31, 2020.

The company has reported EPS of Rs.33.51 for the period ended March 31, 2021 as compared to Rs.47.03 for the period ended March 31, 2020.

Financials	Q4 FY20-21	Q4 FY19-20	% Change
Total Income	₹ 4850.8 crs	₹ 4522.5 crs	7.26%
Net Profit	₹ 557.3 crs	₹ 781.1 crs	-28.65%
EPS	₹ 33.51	₹ 47.03	-28.75%

Financial Results (Year ended FY 20-21) - YoY Comparison

The company has reported total income of Rs.19338.9 crores during the 12 months period ended March 31, 2021 as compared to Rs.18137.6 crores during the 12 months period ended March 31, 2020.

The company has posted net profit / (loss) of Rs.1951.6 crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.2026 crores for the 12 months period ended March 31, 2020.

The company has reported EPS of Rs.117.34 for the 12 months period ended March 31, 2021 as compared to Rs.121.99 for the 12 months period ended March 31, 2020.

Financials	Year Ended FY20-21	Year Ended FY19-20	% Change
Total Income	₹ 19338.9 crs	₹ 18137.6 crs	6.62%
Net Profit	₹ 1951.6 crs	₹ 2026 crs	-3.67%
EPS	₹ 117.34	₹121.99	-3.81%

Commenting on the results, Co-Chairman & MD, G V Prasad said "In FY 21, we continued to grow across all our businesses, enhance productivity and strengthen our development pipeline. We are prioritizing our efforts to launch Sputnik V vaccine across India while working on the development and commercialization of several drugs for the treatment of mild to severe COVID 19 infections."

Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.5302 as compared to the previous close of Rs. 5293.6. The total number of shares traded during the day was 38288 in over 4024 trades.

The stock hit an intraday high of Rs. 5339.75 and intraday low of 5274.05. The net turnover during the day was Rs. 203047658.

Source : Equity Bulls

Keywords